Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.
Jose Maria Jimenez Alvir, DrPH
Advertisement
Articles by Jose Maria Jimenez Alvir, DrPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the One Big Beautiful Bill Act
2
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
3
Genetic Analysis Links Insomnia Liability to Higher Inflammation Marker
4
PBM Reform and Supportive Care Needs: Nicolas Ferreyros
5